Is IRMD Overvalued?

IRMD is now in the Fair zone, suggesting that IRMD current forward PE ratio of 35.60 is considered Fair compare with the five-year average of 43.77.
P/E
EV/EBITDA
P/S
P/B
bubble
P/E

IRMD Competitors Valuation Multiple

P/E
EV/EBITDA
P/S

P/E Multiple

Earnings Growth
Market Cap
stocks logo
IRMD.O
IRadimed Corp
35.60
Average P/E: 56.86
12.74%
712.75M
stocks logo
OFIX.O
Orthofix Medical Inc
loss
8.15%
685.94M
stocks logo
SIBN.O
SI-BONE Inc
loss
36.68%
748.18M
stocks logo
CTKB.O
Cytek Biosciences Inc
28.37
114.95%
659.51M
stocks logo
BWAY.O
Brainsway Ltd
106.62
386.85%
404.79M
stocks logo
STAA.O
STAAR Surgical Co
loss
-540.95%
831.28M

IRMD Revenue Breakdown & PS Ratio Relation

Currency:USD
By Business
By Region
Composition ()
Name
Revenue
Percentage

IRMD FAQs

Is IRMD currently overvalued based on its P/E ratio?

According to the provided data, IRMD's 5-year historical average forward P/E ratio is 43.92. IRMD forward P/E ratio is 35.60, which is categorized as Fair.

How has IRMD's P/E ratio changed over the quarters?

What is the significance of the EV/EBITDA ratio for IRMD?

How has IRMD's Price to Sales (PS) ratio evolved?

What are the key indicators to watch for IRMD's financial performance?

IRMD PE Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
Fair
5Y Average PE
43.77
Current PE
35.60
Overvalued PE
68.09
Undervalued PE
19.46

IRMD EV/EBITDA Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
Fair
5Y Average EV
0.22
Current EV
0.00
Overvalued EV
1.75
Undervalued EV
-1.31

IRMD P/S Ratio

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalued
Fair
5Y Average PS
8.12
Current PS
9.06
Overvalued PS
9.58
Undervalued PS
6.65

Free Financial AI Agent for Investment

Ask any investment related question and get answer instantly

At what price is IRMD undervalued?Is IRMD overvalued compared to its competitors?